Vor Biopharma Inc.
VOR | NASDAQ
$23.57
+$1.68 (+7.67%)
Sep 22, 2026, 11:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 28K | n/a | n/a | n/a | n/a | 865K | n/a | 900K | 943K | 892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -28K | n/a | n/a | n/a | n/a | -865K | n/a | -900K | -943K | -892K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -47.85M | -35.16M | -35.96M | -28.11M | -274.28M | -33.29M | -31.31M | -28.51M | -29.04M | -32.33M | -28.12M | -35.32M | -32.17M | -30.42M | -24.73M | -24.1M | -21.79M | -22.8M | -18.31M | -18.6M | -18.38M | -13.73M |
Interest Income | 4.34M | 3.94M | 2.8M | 1.73M | 537K | 805K | 599K | 954K | 1.2M | 1.52M | 1.86M | 2.13M | 2.2M | 1.99M | 815K | 313K | 133K | 63K | 54K | 48K | 10K | 7K |
Pretax Income | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M | -13.72M |
Net Income | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M | -13.72M |
Selling & General & Admin | 21.93M | 17.54M | 16.77M | 14.42M | 2.4M | 6.59M | 5.1M | 6.7M | 6.31M | 7.06M | 6.34M | 7.71M | 8.28M | 8.51M | 7.66M | 7.23M | 6.46M | 7.52M | 5.61M | 5.68M | 5.41M | 4.79M |
Research & Development | 25.92M | 17.6M | 19.19M | 14.14M | 261.5M | 26.7M | 25.35M | 21.82M | 21.82M | 24.32M | 20.9M | 27.61M | 23.9M | 21.92M | 17.06M | 16.88M | 15.33M | 15.28M | 12.69M | 12.93M | 12.97M | 8.94M |
Other Expenses | n/a | n/a | n/a | -451K | 10.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 47.85M | 35.13M | 35.96M | 28.11M | 274.28M | 33.29M | 30.45M | 28.51M | 28.14M | 31.38M | 27.23M | 35.32M | 32.17M | 30.42M | 24.73M | 24.1M | 21.79M | 22.8M | 18.31M | 18.6M | 18.38M | 13.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -900K | -943K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.85M | 35.16M | 35.96M | 28.11M | 274.28M | 33.29M | 31.31M | 28.51M | 29.04M | 32.33M | 28.12M | 35.32M | 32.17M | 30.42M | 24.73M | 24.1M | 21.79M | 22.8M | 18.31M | 18.6M | 18.38M | 13.73M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 54.3M | 430.12K | 9.87M | 6.68M | 6.26M | 6.24M | 3.44M | 3.42M | 3.41M | 3.4M | 3.39M | 3.38M | 3.35M | 3.31M | 2.32M | 1.9M | 1.87M | 1.86M | 1.85M | 1.85M | 1.84M | 1.11M |
Shares Outstanding (Diluted) | 54.3M | 430.12K | 9.87M | 6.68M | 6.26M | 6.24M | 3.44M | 3.42M | 3.41M | 3.4M | 3.39M | 3.38M | 3.35M | 3.31M | 2.32M | 1.9M | 1.87M | 1.86M | 1.85M | 1.85M | 1.84M | 1.11M |
EPS (Basic) | -1.16 | -510.53 | 307.53 | -121.63 | -251.20 | -5.20 | -9 | -8 | -8.20 | -9 | -7.80 | -9.80 | -9 | -8 | -9.80 | -12.40 | -11.40 | -12.20 | -9.80 | -10 | -10 | -12.40 |
EPS (Diluted) | -1.16 | -510.53 | 44.50 | -121.63 | -251.20 | -5.20 | -9 | -8 | -8.20 | -9 | -7.80 | -9.80 | -9 | -8 | -9.80 | -12.40 | -11.40 | -12.20 | -9.80 | -10 | -10 | -12.40 |
EBITDA | -47.85M | -219.56M | 1.72B | -812.68M | -241.51M | -31.66M | -29.85M | -26.71M | -26.97M | -29.86M | -25.37M | -32.3M | -29.11M | -27.6M | -23.28M | -22.9M | -19.77M | -22.31M | -17.86M | -18.18M | -18.02M | -13.42M |
EBIT | -47.85M | -219.59M | 1.72B | -812.68M | -243.55M | -32.49M | -30.71M | -27.56M | -27.84M | -30.8M | -26.26M | -33.19M | -29.98M | -28.43M | -23.91M | -23.79M | -21.66M | -22.74M | -18.25M | -18.55M | -18.37M | -13.73M |
Depreciation & Amortization | n/a | 28K | 23K | 2K | 2.04M | 825K | 865K | 851K | 869K | 943K | 892K | 893K | 870K | 837K | 632K | 892K | 1.89M | 426K | 395K | 374K | 354K | 311K |
Add to Watchlist
Select watchlists to add or remove VOR